Tags

Type your tag names separated by a space and hit enter

Pathophysiology, clinical features and management of hepatorenal syndrome.
Eur Rev Med Pharmacol Sci. 1998 Sep-Dec; 2(5-6):181-4.ER

Abstract

Hepatorenal syndrome (HRS) is a form of functional renal failure occurring in patients with advanced liver disease. Hypoperfusion of the kidney, due to renal vasoconstriction, is the main feature of HRS. Conversely, the extrarenal circulation is characterized by low systemic resistance, especially occurring in splanchnic vessels, and arterial hypotension. It has been postulated that renal vasoconstriction is induced either by a hepatorenal reflex related to the diseased liver or by arterial vasodilation and the subsequent baroreceptor-mediator activation of systemic vasoconstrictor factors. The diagnosis of HRS requires the exclusion of other causes of renal failure in patients with liver disease. On the basis of clinical and prognostic differences, two types of HRS have been defined. The prognosis of HRS is poor and, to date, the only effective treatment is the liver transplantation.

Authors+Show Affiliations

Department of Clinical Medicine, University of Rome La Sapienza, Italy.No affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article
Review

Language

eng

PubMed ID

10710816

Citation

Garzia, P, et al. "Pathophysiology, Clinical Features and Management of Hepatorenal Syndrome." European Review for Medical and Pharmacological Sciences, vol. 2, no. 5-6, 1998, pp. 181-4.
Garzia P, Ferri GM, Ilardi M, et al. Pathophysiology, clinical features and management of hepatorenal syndrome. Eur Rev Med Pharmacol Sci. 1998;2(5-6):181-4.
Garzia, P., Ferri, G. M., Ilardi, M., Messina, F. R., & Amoroso, A. (1998). Pathophysiology, clinical features and management of hepatorenal syndrome. European Review for Medical and Pharmacological Sciences, 2(5-6), 181-4.
Garzia P, et al. Pathophysiology, Clinical Features and Management of Hepatorenal Syndrome. Eur Rev Med Pharmacol Sci. 1998 Sep-Dec;2(5-6):181-4. PubMed PMID: 10710816.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Pathophysiology, clinical features and management of hepatorenal syndrome. AU - Garzia,P, AU - Ferri,G M, AU - Ilardi,M, AU - Messina,F R, AU - Amoroso,A, PY - 2000/3/11/pubmed PY - 2000/3/11/medline PY - 2000/3/11/entrez SP - 181 EP - 4 JF - European review for medical and pharmacological sciences JO - Eur Rev Med Pharmacol Sci VL - 2 IS - 5-6 N2 - Hepatorenal syndrome (HRS) is a form of functional renal failure occurring in patients with advanced liver disease. Hypoperfusion of the kidney, due to renal vasoconstriction, is the main feature of HRS. Conversely, the extrarenal circulation is characterized by low systemic resistance, especially occurring in splanchnic vessels, and arterial hypotension. It has been postulated that renal vasoconstriction is induced either by a hepatorenal reflex related to the diseased liver or by arterial vasodilation and the subsequent baroreceptor-mediator activation of systemic vasoconstrictor factors. The diagnosis of HRS requires the exclusion of other causes of renal failure in patients with liver disease. On the basis of clinical and prognostic differences, two types of HRS have been defined. The prognosis of HRS is poor and, to date, the only effective treatment is the liver transplantation. SN - 1128-3602 UR - https://www.unboundmedicine.com/medline/citation/10710816/Pathophysiology_clinical_features_and_management_of_hepatorenal_syndrome_ L2 - http://www.diseaseinfosearch.org/result/3341 DB - PRIME DP - Unbound Medicine ER -